Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | CA4 | P22748 | 3/20 | 0.43 |
| ▸ | CA5A | P35218 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6533217 | 0.84 | ALDH1A1 (0.38) | BCAT2CDK2CA2ALDH1A1CA12 | |
| Phenolsulphonic Acid SCHEMBL8352680 | 0.81 | LMNA (0.46) | CDK2CA2TDP1CA4CA5A | |
| SCHEMBL6828498 | 0.81 | CDK2 (0.48) | BCAT2CDK2CA2TDP1ALDH1A1 | |
| SCHEMBL8106699 | 0.81 | LOX (0.47) | BCAT2CA2CA4CA5AALDH1A1 | |
| SCHEMBL1577598 | 0.79 | TRPA1 (0.48) | BCAT2CDK2CA2TDP1ALDH1A1 | |
| SCHEMBL11168990 | 0.79 | CDK2 (0.53) | CDK2CA2CA4CA5ACA12 | |
| SCHEMBL11149914 | 0.79 | CA2 (0.47) | CDK2CA2TDP1CA4CA5A | |
| SCHEMBL2030350 | 0.79 | ALDH1A1 (0.47) | CDK2CA2TDP1CA4CA5A | |
| SCHEMBL29381412 | 0.79 | TDP1 (0.50) | CDK2CA2TDP1CA4CA5A | |
| SCHEMBL18837 | 0.79 | TDP1 (0.50) | CDK2CA2TDP1CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11804334-B2 | Electrolytic capacitor comprising an anode body, a cathode body and a conductive polymer and a liquid component disposed between the anode body and the cathode body | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2023-10-31 | — | — | US | claimed |
| CN-115798935-A | Electrolytic capacitor | 松下知识产权经营株式会社 | 2023-03-14 | — | — | CN | claimed |
| CN-111383845-B | Electrolytic capacitor | 松下知识产权经营株式会社 | 2023-01-24 | — | — | CN | claimed |
| US-20220399170-A1 | ELECTROLYTIC CAPACITOR COMPRISING AN ANODE BODY, A CATHODE BODY AND A CONDUCTIVE POLYMER AND A LIQUID COMPONENT DISPOSED BETWEEN THE ANODE BODY AND THE CATHODE BODY | PANASONIC IP MAN CO LTD (JP) | 2022-12-15 | — | — | US | claimed |
| US-11456120-B2 | Electrolytic capacitor comprising an anode body, a cathode body and a conductive polymer and a liquid component disposed between the anode body and the cathode body | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2022-09-27 | — | — | US | claimed |
| CN-111383845-A | Electrolytic capacitor | 松下知识产权经营株式会社 | 2020-07-07 | — | — | CN | claimed |
| US-20200211785-A1 | ELECTROLYTIC CAPACITOR | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2020-07-02 | — | — | US | claimed |
| US-9870909-B2 | Compositions and methods for mass spectometry | MSTM, LLC | 2018-01-16 | — | — | US | claimed |
| EP-3233077-B1 | DOPAMINE D2 RECEPTOR LIGANDS | BROAD INST INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260022099-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | NEXYS THERAPEUTICS, INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-12428373-B2 | Dopamine D2 receptor ligands | THE BROAD INSTITUTE, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12371408-B2 | Aryl hydrocarbon receptor agonists and uses thereof | NEXYS THERAPEUTICS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-12168646-B2 | Aryl hydrocarbon receptor agonists and uses thereof | NEXYS THERAPEUTICS, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| EP-4472953-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | Nexys Therapeutics, Inc. (US) | 2024-12-11 | — | — | EP | disclosed |
| US-4567264-A | ADRENERGIC BLOCKING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1986-01-28 | — | — | US | disclosed |
| EP-0126449-A1 | Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry | SYNTEX (U.S.A.) INC. (US) | 1984-11-28 | — | — | EP | disclosed |
| EP-0013909-A1 | Pigment dispersions and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-08-06 | — | — | EP | disclosed |
| US-4119729-A | TREATMENT OF HYPERTENSION | MEAD JOHNSON & COMPANY (US) | 1978-10-10 | — | — | US | disclosed |
| US-4067904-A | ANTIARRHYTHMIA, HYPOTENSIVE | MEAD JOHNSON & COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4048229-A | ANTAGONIST ACTIVITY | SMITHKLINE CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371408-B2 | Aryl hydrocarbon receptor agonists and uses thereof | AHR, ARNT, NR1H2 | BCAT2 1899/4885CDK2 3767/4885CA2 4744/4885 |
| US-20260022099-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | AHR, NR1H4, CNR1 | BCAT2 1957/4885CDK2 3827/4885CA2 3205/4885 |
| US-12428373-B2 | Dopamine D2 receptor ligands | DRD2, SLC6A3, NTSR2 | BCAT2 2422/4885CDK2 1679/4885CA2 4162/4885 |
| US-12168646-B2 | Aryl hydrocarbon receptor agonists and uses thereof | AHR, ARNT, NR1H2 | BCAT2 1899/4885CDK2 3767/4885CA2 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.